REPROS THERAPEUTICS INC. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b03f6457-ff6c-4218-8247-4f0627d53a20/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2016 | $47.0k | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-017919 |
| FY 2015 | $11.0k | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-087730 |
| FY 2014 | $9.0k | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-016200 |
| FY 2013 | $48.0M | 1987-08-20 – 2014-03-31 | evidence 0001144204-14-029339 |
| FY 2012 | $48.0M | 1987-08-20 – 2013-03-31 | evidence 0001144204-13-027766 |
| FY 2011 | $48.0M | 1987-08-20 – 2012-03-31 | evidence 0001144204-12-029142 |
| FY 2010 | $421.0k | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-017347 |
| FY 2009 | $551.0k | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-017347 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).